156 related articles for article (PubMed ID: 30377659)
1. Hepatitis B vaccination using a dissolvable microneedle patch is immunogenic in mice and rhesus macaques.
Perez Cuevas MB; Kodani M; Choi Y; Joyce J; O'Connor SM; Kamili S; Prausnitz MR
Bioeng Transl Med; 2018 Sep; 3(3):186-196. PubMed ID: 30377659
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B vaccine delivered by microneedle patch: Immunogenicity in mice and rhesus macaques.
Choi Y; Lee GS; Li S; Lee JW; Mixson-Hayden T; Woo J; Xia D; Prausnitz MR; Kamili S; Purdy MA; Tohme RA
Vaccine; 2023 Jun; 41(24):3663-3672. PubMed ID: 37179166
[TBL] [Abstract][Full Text] [Related]
3. Progress Toward Hepatitis B Control - South-East Asia Region, 2016-2019.
Sandhu HS; Roesel S; Sharifuzzaman M; Chunsuttiwat S; Tohme RA
MMWR Morb Mortal Wkly Rep; 2020 Jul; 69(30):988-992. PubMed ID: 32730237
[TBL] [Abstract][Full Text] [Related]
4. Countries' interest in a hepatitis B vaccine licensed for the controlled temperature chain; survey results from African and Western Pacific regions.
Petit D; Tevi-Benissan C; Woodring J; Hennessey K; Kahn AL
Vaccine; 2017 Dec; 35(49 Pt B):6866-6871. PubMed ID: 29132994
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of birth-dose hepatitis B vaccination among refugee populations in the African region: a series of case studies.
Reardon JM; O'Connor SM; Njau JD; Lam EK; Staton CA; Cookson ST
Confl Health; 2019; 13():5. PubMed ID: 30858875
[TBL] [Abstract][Full Text] [Related]
6. The coverage of hepatitis B birth dose vaccination in Nigeria: Does the place of delivery matter?
Olakunde BO; Adeyinka DA; Olakunde OA; Ogundipe T; Oladunni F; Ezeanolue EE
Trans R Soc Trop Med Hyg; 2022 Apr; 116(4):359-368. PubMed ID: 34453162
[TBL] [Abstract][Full Text] [Related]
7. Barriers and facilitators to hepatitis B birth dose vaccination: Perspectives from healthcare providers and pregnant women accessing antenatal care in Nigeria.
Freeland C; Kanu F; Mohammed Y; Nwokoro UU; Sandhu H; Ikwe H; Uba B; Asekun A; Akataobi C; Adewole A; Fadahunsi R; Wisdom M; Akudo OL; Ugbenyo G; Simple E; Waziri N; Vasumu JJ; Bahuli AU; Bashir SS; Isa A; Ugwu GO; Obi EI; Binta H; Bassey BO; Shuaib F; Bolu O; Tohme RA
PLOS Glob Public Health; 2023; 3(6):e0001332. PubMed ID: 37289735
[TBL] [Abstract][Full Text] [Related]
8. Implementing a Birth Dose of Hepatitis B Vaccine in Africa: Findings from Assessments in 5 Countries.
Moturi E; Tevi-Benissan C; Hagan JE; Shendale S; Mayenga D; Murokora D; Patel M; Hennessey K; Mihigo R
J Immunol Sci; 2018 Aug; Suppl(5):31-40. PubMed ID: 30931434
[TBL] [Abstract][Full Text] [Related]
9. Implications of Birth-Dose Vaccination against Hepatitis B Virus in Southeast Asia.
Akbar SMF; Al Mahtab M; Begum F; Hossain SAS; Sarker S; Shrestha A; Khan MSI; Yoshida O; Hiasa Y
Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33921259
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B vaccine stored outside the cold chain setting: a pilot study in rural Lao PDR.
Kolwaite AR; Xeuatvongsa A; Ramirez-Gonzalez A; Wannemuehler K; Vongxay V; Vilayvone V; Hennessey K; Patel MK
Vaccine; 2016 Jun; 34(28):3324-30. PubMed ID: 27040399
[TBL] [Abstract][Full Text] [Related]
11. Microneedle patches for vaccination in developing countries.
Arya J; Prausnitz MR
J Control Release; 2016 Oct; 240():135-141. PubMed ID: 26603347
[TBL] [Abstract][Full Text] [Related]
12. Implementation of newborn hepatitis B vaccination--worldwide, 2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1249-52. PubMed ID: 19023261
[TBL] [Abstract][Full Text] [Related]
13. Rabies vaccination in dogs using a dissolving microneedle patch.
Arya JM; Dewitt K; Scott-Garrard M; Chiang YW; Prausnitz MR
J Control Release; 2016 Oct; 239():19-26. PubMed ID: 27524283
[TBL] [Abstract][Full Text] [Related]
14. Barriers to Timely Administration of Hepatitis B Birth Dose Vaccine to Neonates of Mothers With Hepatitis B in Ghana: Midwives' Perspectives.
Adjei CA; Suglo D; Ahenkorah AY; MacDonald SE; Richter S
SAGE Open Nurs; 2023; 9():23779608231177547. PubMed ID: 37261100
[TBL] [Abstract][Full Text] [Related]
15. A microneedle patch containing measles vaccine is immunogenic in non-human primates.
Edens C; Collins ML; Goodson JL; Rota PA; Prausnitz MR
Vaccine; 2015 Sep; 33(37):4712-8. PubMed ID: 25770786
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of a combination diphtheria-tetanus toxoids-acellular pertussis-hepatitis B vaccine administered at two, four and six months of age compared with monovalent hepatitis B vaccine administered at birth, one month and six months of age.
Greenberg DP; Wong VK; Partridge S; Howe BJ; Ward JI
Pediatr Infect Dis J; 2002 Aug; 21(8):769-77. PubMed ID: 12192167
[TBL] [Abstract][Full Text] [Related]
17. Perinatal hepatitis B prevention program in Shandong Province, China. Evaluation and progress.
Zhang L; Ko S; Lv J; Ji F; Yan B; Xu F; Xu A
Hum Vaccin Immunother; 2014; 10(9):2755-60. PubMed ID: 25483482
[TBL] [Abstract][Full Text] [Related]
18. Dissolvable microneedle patches for the delivery of cell-culture-derived influenza vaccine antigens.
Kommareddy S; Baudner BC; Oh S; Kwon SY; Singh M; O'Hagan DT
J Pharm Sci; 2012 Mar; 101(3):1021-7. PubMed ID: 22190403
[TBL] [Abstract][Full Text] [Related]
19. Progress in hepatitis B prevention through universal infant vaccination--China, 1997-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 May; 56(18):441-5. PubMed ID: 17495790
[TBL] [Abstract][Full Text] [Related]
20. Novel Whole-Cell Inactivated
Gala RP; Zaman RU; D'Souza MJ; Zughaier SM
Vaccines (Basel); 2018 Sep; 6(3):. PubMed ID: 30181504
[No Abstract] [Full Text] [Related]
[Next] [New Search]
